Alkermes, Inc.
Edit Page
Report
Scan day: 05 February 2014 UTC
8
Virus safety - good
Description: Develops sustained-release injectables and inhalers for delivering drugs such as insulin. Includes product details, technology, investor news and contacts in Ohio and their headquarters in Cambridge, Massachusetts. (Nasdaq: ALKS)
Alkermes plc – A Global Biopharmaceutical Company Alkermes applies its scientific expertise and technological know-how to develop innovative medicines designed to help patients with serious, chronic conditions better manage their disease.
Size: 248 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Alkermes plc – A Global Biopharmaceutical Company |
| Keywords: | pharmaceutical company, pharmaceutical technology, drug delivery, drug delivery technology, opioid dependence drug, alcohol dependence drug, schizophrenia drug, ms drug, multiple sclerosis drug, diabetes drug, long-acting drug, LAI |
| Description: | Alkermes plc develops innovative medicines designed to help patients with serious, chronic conditions better manage their disease. |
| IP-address: | 50.56.52.132 |
WHOIS Info
| NS | Name Server: NS59.WORLDNIC.COM Name Server: NS60.WORLDNIC.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 03-oct-1995 Expiration Date: 02-oct-2014 |